Open AccessPneumocystis jiroveciiDisease: Basis for the Revised EORTC/MSGERC Invasive Fungal Disease Definitions in Individuals Without Human Immunodeficiency Virus
Author(s) -
Katrien Lagrou,
Sharon Chen,
Henry Masur,
Claudio Viscoli,
Catherine F. Decker,
Livio Pagano,
Andreas H. Groll
Publication year - 2021
Publication title -
clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciaa1805
Subject(s) - pneumocystis jirovecii , medicine , pneumocystis pneumonia , disease , pneumonia , epidemiology , immunology , intensive care medicine , pathology
Pneumocystis jirovecii pneumonia (PCP) causes substantive morbidity in immunocompromised patients. The EORTC/MSGERC convened an expert group to elaborate consensus definitions for Pneumocystis disease for the purpose of interventional clinical trials and epidemiological studies and evaluation of diagnostic tests.